Trials / Unknown
UnknownNCT03548740
Diversity Analysis of Vaginal Microbiota on Women With High-risk Human Papillomavirus Infection
Diversity Analysis of Vaginal Microbiota on Women With High-risk Human Papillomavirus Infection and Cervical Cytological Abnormalities.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 151 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- Female
- Age
- 25 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Since other genital infections enhance HIV susceptibility by inducing inflammation, the investigators study the relationship between the vaginal microbiota composition and the risk of HPV infection, cervical cytological abnormalities.
Detailed description
Persistent infection with oncogenic Human Papillomavirus (HPV) is necessary but not sufficient for the development of cervical cancer. Additional factors correlated with HPV persistence include immunodeficiency caused by HIV, smoking, use of oral contraceptives and, more recently reported, vaginal dysbiosis. In a state of dysbiosis, there is a marked reduction of Lactobacillus and a high diversity of bacteria, with increased abundance of anaerobic bacterial species. Based on this, the investigators are going to analyze the changes of microbiota in women with high-risk HPV and the cervical lesions. And the investigators hope to figure out the difference and change in microbiota to realize the tanning of cervical lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Human Papillomavirus | women with high-risk Human Papillomavirus or not |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2020-01-20
- Completion
- 2020-05-20
- First posted
- 2018-06-07
- Last updated
- 2019-02-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03548740. Inclusion in this directory is not an endorsement.